These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32130695)

  • 21. Host-microbiota interactions in the intestine.
    Elson CO; Alexander KL
    Dig Dis; 2015; 33(2):131-136. PubMed ID: 25925913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in
    Heimesaat MM; Mrazek K; Bereswill S
    Front Immunol; 2019; 10():2272. PubMed ID: 31616437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
    Wang W; Fan J; Zhang C; Huang Y; Chen Y; Fu S; Wu J
    Microbiol Res; 2024 May; 282():127668. PubMed ID: 38430889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging.
    Biragyn A; Ferrucci L
    Lancet Oncol; 2018 Jun; 19(6):e295-e304. PubMed ID: 29893261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCFA: mechanisms and functional importance in the gut.
    Martin-Gallausiaux C; Marinelli L; Blottière HM; Larraufie P; Lapaque N
    Proc Nutr Soc; 2021 Feb; 80(1):37-49. PubMed ID: 32238208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota in autoimmunity: potential for clinical applications.
    Kim D; Yoo SA; Kim WU
    Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.
    Ha CW; Lam YY; Holmes AJ
    World J Gastroenterol; 2014 Nov; 20(44):16498-517. PubMed ID: 25469018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota - architects of small intestinal capillaries.
    Khandagale A; Reinhardt C
    Front Biosci (Landmark Ed); 2018 Jan; 23(4):752-766. PubMed ID: 28930570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis.
    Nagai M; Obata Y; Takahashi D; Hase K
    Int Immunopharmacol; 2016 Aug; 37():79-86. PubMed ID: 27133028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
    Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harness the functions of gut microbiome in tumorigenesis for cancer treatment.
    Lee MH
    Cancer Commun (Lond); 2021 Oct; 41(10):937-967. PubMed ID: 34355542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism at the centre of the host-microbe relationship.
    Maslowski KM
    Clin Exp Immunol; 2019 Aug; 197(2):193-204. PubMed ID: 31107965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diet-microbiota-metabolite axis regulates the host physiology.
    Yamada T; Takahashi D; Hase K
    J Biochem; 2016 Jul; 160(1):1-10. PubMed ID: 26970281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
    Cristofori F; Dargenio VN; Dargenio C; Miniello VL; Barone M; Francavilla R
    Front Immunol; 2021; 12():578386. PubMed ID: 33717063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota in Intestinal and Liver Disease.
    Jones RM; Neish AS
    Annu Rev Pathol; 2021 Jan; 16():251-275. PubMed ID: 33234022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.